- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Alirocumab – November 2017
Alirocumab: Injection 75 mg in 1 mL single dose pre-filled pen, Injection 150 mg in 1 mL single dose pre-filled pen; Praluent®
Last updated
16 March 2018